The 17th International Congress on Photosynthesis Research will be held August 7-12, 2016 in Maastricht, The Netherlands. The congress will include 14 plenary lectures, 32 scientific symposia, poster sessions, exhibitors, opening reception, party, social program, final banquet and excursions. The congress is organized as an official event sponsored by the International Society of Photosynthesis Research. The overall organization of the congress will be co-chaired by Prof. Dr. Herbert van Amerongen, Wageningen University, The Netherlands and Prof. Dr. Roberta Croce, VU University Amsterdam, The Netherlands and will be advised by the former president of the ISPR, Prof. Dr. Bill Rutherford. ... [Information of the supplier]
We are pleased to confirm the 18th International Congress on Photosynthesis Research will take place August 7 – 12, 2022. However, at the current time the New Zealand government expects that in August the border will be only partially open and visitors to the country will still need to quarantine. Therefore, the Congress will be presented in a virtual format, thus enabling everyone to fully participate. By working with online meeting professionals, the virtual format will optimise personal interactions and also allow the meeting to be recorded. This will enable attendees to catch up on any aspects they had to miss while providing the added benefit of not disturbing biological clocks too badly. ... [Information of the supplier]
The oxygen evolving complex (OEC) of photosystem II is responsible for the formation of atmospheric oxygen. Cytochrome oxidase (CO) and related respiratory oxidases convert oxygen back into water as part of the respiratory processes that provide the energy for survival of most living organisms. The underlying redox chemistry of oxygen/water interconversion is complex and these enzymes have evolved unique mechanisms whose performance has yet to be achieved with (bio)mimetic chemical systems. Mechanistic and structural questions are common and yet the two enzyme systems are rarely discussed comparatively. The format of this Harden meeting is designed to bring together such expertise. ... [Information of the supplier]
The degradation of xenobiotic and other toxic compounds by microorganisms is central to strategies for the bioremediation of contaminated environments. The Center for Microbial Ecology at Michigan State University and Rutgers University initiated a study to establish the phylogenetic distribution of described, biodegrading microorganisms with the goals of identifying patterns of microbial degradative processes within a phylogenetic context and of gaining insights into the evolution of those processes. This continuing investigation has been hindered by strain data that is difficult to comprehensively compile and often uncomparable between strains and has underscored the potential usefulness of a database that would consolidate strain-level microbial data. To address this need and provide a resource for the scientific community, we have developed the Biodegradative Strain Database (BSD). The BSD is being developed at the Center for Microbial Ecology in collaboration with the University of Minnesota Biocatalysis/Biodegradation Database and the Ribosomal Database Project II . It should consolidate and provide rapid access to comparative data on known biodegradative microorganisms and the hazardous substances they degrade as a readily accessible resource for researchers and field practitioners. One of its other goals is to facilitate comparative analyses and highlight deficiencies in our current knowledge base. ... [Information of the supplier, modified]
The word "aging" encompasses a range of physiological changes in humans, human tissues, and constituent cells. Alterations in metabolism, whether at the level of small molecules, protein homeostasis, signaling patterns, or intertissue communication, underpin many of the processes that ultimately decline or shift during aging. The recent wealth of information on how perturbation of metabolic factors can accelerate or impair aging processes makes this an exciting time to convene and consider the new biology being uncovered, its potential impact on human health, and the implications for the coming age of precision medicine. This meeting brings together scientists who have interests in aging and metabolism to explore the growing intersection between these fields and to discuss key questions in this area for human health and disease. Leaders in the field will share results from cellular research, investigations in model organisms, and studies with translational impact rooted in mammalian systems. ... [Editorial staff vifabio]
This meeting brings together scientists who have interests in aging, metabolism, and immunology to explore the growing intersection between these fields and to discuss key questions and important areas of future investigation. Our aim is to spur the progress of efforts to elucidate the mechanisms underlying the aging process, so as to inform current approaches of disease treatment and prevention, and to provide an improved understanding of healthy aging. ... [Information of the supplier]
The field of immunometabolism has thrived over the last decade, revealing not only the major roles played by immune cells in metabolic homeostasis but also the impact of metabolic pathways on immune cell function. As new discoveries continue to reveal the intricate links between immunology and metabolism, a key question arises: will our accumulated knowledge on immunometabolic deregulations translate into novel therapies for human diseases? During this Cell Symposium, you will hear about the latest advances in immunometabolism from physician-scientists, basic researchers and industry leaders. We will discuss how local and systemic metabolism are integrated at the cellular level to regulate immune cell function and we will focus on how novel insights into immunometabolism can be harnessed to advance and/or bolster therapeutic interventions in metabolic diseases, inflammation, autoimmunity, and cancer. ... [Information of the supplier]
This page gives access to the digitized version of the Roche Applied Science "Biochemical Pathways" wall chart. The Biochemical Pathway posters are available as paper copy from Roche. Please enter one or more keyword(s) or partial word(s). For example, you may type Oxoacyl. You will then be given a list of all matching entries of the "Biochemical Pathways" wall chart. This list contains links to the ENZYME Database and, for each entry, links to all maps of "Biochemical Pathways" in which this entry appears. You can also access the individual images by clicking in a reduced image of an entire section of the wall chart (thumbnail view for "Metabolic Pathways" and "Cellular and Molecular Processes"). ... [Information of the supplier, modified]
hiPathDB provides two different types of integration. The pathway-level integration is a simple collection of individual pathways as described in the original database. We devised a gene-centric pathway model that could reflect different properties of four databases. The entity-level integration creates a super pathway that merged all pathways by unifying redundant components. Even though the detailed molecular information such as complex formation or modification can be lost in some cases, the merged superpathway provides a unified view of current knowledge on human pathways, which is critical to understand relationships among different pathways. Another strong merit of hiPathDB is the built-in pathway visualization module to support explorative study of complex networks in an interactive fashion. The force-directed layout algorithm is optimized for almost automatic visualization of pathways. ... [Information of the supplier]
The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body. It is intended to be used for applications in metabolomics, clinical chemistry, biomarker discovery and general education. The database is designed to contain or link three kinds of data: 1) chemical data, 2) clinical data, and 3) molecular biology/biochemistry data. The database currently contains nearly 2500 metabolite entries including both water-soluble and lipid soluble metabolites as well as metabolites that would be regarded as either abundant (> 1 uM) or relatively rare (< 1 nM). ... [Information of the supplier]
